Biomarker Tied To Success Of GlobeImmune's Therapeutic Hep C Vaccine In Patients With Poor Prognosis

For GlobeImmune, the pharmacogenomic implications are important not only as a predictor of response to interferon, but also as a predictor of how the GI-5005 vaccine behaves. The company is tailoring its Phase III approach using that information.